Rethinking CQV: The Power of AI-Enhanced Expertise

How Efor’s Valimate is helping transform CQV activities and strengthen project delivery. 

The pharmaceutical industry faces growing pressure to deliver complex manufacturing projects efficiently while maintaining the highest standards of quality, compliance, and patient safety. 

Commissioning, qualification and validation (CQV) plays a critical role during facility start-up ensuring that facilities, equipment, and systems operate as intended and meet regulatory requirements. 

Yet CQV remains a complex and demanding activity, involving extensive documentation, repetitive tasks, and rigorous reviews. Inconsistencies, missing requirements, or documentation gaps can lead to costly rework, delayed approvals, and increased project risk. On new projects, right-first-time rates for documentation preparation can be as low as 50%, highlighting the challenge of achieving consistent quality from the outset. 

What if artificial intelligence (AI) could help teams get things right the first time, while strengthening quality and compliance? 

Valimate: An Intelligent Assistant for Validation Experts 

Developed by Efor, Valimate combines AI with established pharmaceutical validation expertise to support consistent, high-quality documentation while maintaining full control over technical and compliance decisions. 

Preparing test protocols requires interpreting extensive documentation, regulatory requirements, and test cases. While AI can generate content quickly and cost-effectively, producing reliable, context-specific protocols demands a more sophisticated approach. 

This is where Valimate brings added value. It connects project requirements with Efor’s library of validation best practices, suggesting relevant tests, adapting them to equipment-specific requirements, and identifying potential gaps in test coverage.  

Importantly, it ensures traceability of information to its original sources, allowing validation professionals to verify technical details, such as equipment specifications, instrument lists, and tag numbers with greater confidence Furthemore, qualified validation professionals remain responsible for reviewing and approving deliverables, ensuring AI supports rather than replaces professional judgement 

Turning Technology into Tangible Client Value 

For life science companies, Valimate’s true value lies in its ability to improve the quality, reliability, and predictability of CQV delivery, supporting:  

• Right-first-time quality: By leveraging established validation practices and CQV methodology, Valimate ensures consistent, complete and compliant documentation helping to reduce errors review cycles, and rework. 

• Greater traceability, reduced project risk: Earlier identification of documentation gaps and clear links to source information support effective reviews and help prevent delays. 

• More predictable project delivery: By structuring documentation preparation into clear, manageable steps, Valimate simplifies workflows and helps protect critical milestones. 

• More value from expert resources: Reducing repetitive tasks, such as copying templates, searching for technical information, and manually updating documents, frees professionals to focus on technical challenges and critical quality decisions. 

Designed to complement existing digital validation platforms, Valimate can integrate with clients’ established systems and adapt to their specific procedures and quality requirements, helping life science companies to build on their existing digital investments. 

Shaping the Future of CQV: Innovation Guided by Human Expertise 

In highly regulated environments, the successful use of AI requires robust governance, transparency, and clear accountability. For Efor, these principles are fundamental: technology can transform how validation activities are performed, but critical decision-making must remain firmly in the hands of qualified experts. 

As pharmaceutical manufacturing evolves, AI offers opportunities to go beyond automating documentation- towards more proactive, intelligent, and quality-driven validation practices. 

With Valimate, Efor is bringing this vision to its CQV services, combining innovation with technical rigor. 

The future of CQV is not about replacing human expertise with technology, but combining their strengths to deliver smarter, more reliable, validation.